Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GlaxoSmithKline launches new bioelectronics research award scheme

GlaxoSmithKline launches new bioelectronics research award scheme

23rd December 2013

GlaxoSmithKline has announced the launch of a new innovation award scheme for scientists working in the field of bioelectronic research.

The company wishes to help accelerate progress in this emerging area and is therefore offering $1 million (611,700 pounds) to the team that can successfully create a miniaturised, fully implantable device that reads, writes and blocks the body's electrical signals to treat disease.

This new challenge was developed and agreed by a group of approximately 150 leading scientists from around the world. It is thought that the development of such a device can greatly aid the onward development of bioelectronic medicines as a future therapeutic reality.

By reading and correcting the electrical signals that pass along the nerves of the body, scientists could open up all sorts of new approaches to treating conditions as diverse as inflammatory bowel disease, arthritis, asthma, hypertension and diabetes.

GlaxoSmithKline's bioelectronics research and development unit has also launched the first wave of 15 exploratory research projects agreed with international academics, in order to facilitate further discoveries in this field.

This comes after the company formed a major new collaborative cancer research project known as the Oncology Clinical and Translational Consortium earlier this week, spanning six internationally renowned comprehensive cancer centres worldwide.ADNFCR-8000103-ID-801675467-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.